Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-044241
Filing Date
2024-04-15
Accepted
2024-04-15 09:01:55
Documents
4
Period of Report
2024-04-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A copy_of_igm_pre14a_fy202.htm PRE 14A 1304054
2 GRAPHIC img112834731_0.jpg GRAPHIC 128304
3 GRAPHIC img112834731_1.jpg GRAPHIC 494950
4 GRAPHIC img112834731_2.jpg GRAPHIC 214112
  Complete submission text file 0000950170-24-044241.txt   2454947
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39045 | Film No.: 24843257
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)